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Abstract
Background: This is the first case report of focal seizure as a manifestation of Immunoglobulin G4 (IgG4)-related
hypophysitis. IgG4-related hypophysitis is a novel category of hypophysitis. The clinical presentations, imaging
studies and initial pathology studies can mimic lymphocytic hypophysitis. Here we report additional clinical clues
in differentiating these two conditions.
Case presentation: A 43-year-old Thai male presented with focal seizure, headache, and anterior pituitary
hypofunction. His MRI study showed typical hypophysitis lesion with abnormal cerebral parenchymal signal
intensity at right frontal lobe. The pituitary biopsied was obtained and the patient was initially diagnosed with
lymphocytic hypophysitis. Following initial low-dose steroid therapy, his seizure and headache resolved but his
anterior pituitary hormones remained deficient. However, during steroid tapering, he developed new onset acute
visual loss. Upon rigorous pathologic review, his diagnosis of IgG4-related hypophysitis with suspected CNS
involvement was established. He was subsequently treated with high-dose steroid and rapidly regained his sight.
Conclusion: This case report highlights the important distinguishing features of IgG4-related hypophysitis from
lymphocytic hypophysitis. These include the relapsing clinical course of hypophysitis after steroid decrement and
concomitant pachymeningitis particularly in middle-aged to elderly Asian male who presented with hypophysitis.
With appropriate dosage of steroids, medical treatment is usually sufficient to control the disease and surgical
interventions are usually not required.
Keywords: IgG4-related disease, Hypophysitis, Relapsing lymphocytic hypophysitis, Inflammatory pituitary mass,
Pachymeningitis
Background
Immunoglobulin G4 (IgG4)-related disease is a fibroin-
flammatory disease characterized by fibrous tissue and
lymphoplasmocytic infiltration [1]. IgG4-related hypophy-
sitis is a novel classification of primary hypophysitis. It
may be associated with other organ involvements or
confined in the pituitary [2]. The presence of IgG4-related
systemic diseases, the elevation of serum IgG4 level, and
the dramatic response to steroid therapy are important
clinical clues to establish the diagnosis of IgG4-related
hypophysitis [2, 3]. However, there is an extensive overlap
between the clinical spectrum of lymphocytic hypophysitis
and IgG4-related hypophysitis. To differentiate these
conditions based on clinical manifestations can be prob-
lematic. We thereby present other clinical clues that may
support the diagnosis of IgG4-related hypophysitis.
Case presentation
Patient information and clinical findings
In September 2013, a 43-year-old Thai man was admitted
to the hospital with three consecutive episodes of rhyth-
mic jerky movement of left face and arm, as well as speech
arrest. These symptoms spontaneously resolved prior to
hospital arrival. He also had a two-year history of malaise,
loss of appetite, cold intolerance, 10-kg weight loss, head-
ache, and loss of libido. Upon initial physical examination,
there was no residual neurological deficit. His visual acuity
and visual fields were normal in both eyes. A brain MRI
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revealed T1W hypointense and T2W hyperintense lesion
at right frontal lobe with gyral enhancement (Fig. 1a, b).
There was a homogeneous enhancing sellar-suprasellar
mass that was abutted to the optic chiasm with pituitary
stalk enlargement (Fig. 2a, b) and loss of posterior bright
spot. At this point, a neurologist suspected that he had a
subacute cerebral infarction with pituitary incidentaloma.
An endocrine assessment at the presentation revealed
multiple anterior pituitary hormone deficiencies without
diabetes insipidus (Table 1). Due to the unavailability of
Growth hormone releasing hormone and glucagon, Growth
hormone stimulation test was not performed at that time.
Insulin tolerance test was also omitted due to the concern
of recurrent seizure. Serum alpha-fetoprotein and beta-
human chorionic gonadotropin were within normal limits.
Anti-thyroperoxidase and Anti-thyroglobulin were negative.
He was initially treated with 15 mg of prednisolone daily,
levothyroxine replacement, low dose aspirin, simvastatin
and phenytoin. The patient gradually improved and was
discharged two weeks later.
Since the diagnosis was subacute cerebral infarction, the
pituitary biopsy was postponed until six weeks follow-up.
We sent separated pituitary tissue for pathologic examin-
ation, one for a local pathologist and other to an external
pathology laboratory. The tissue that was sent to the local
pathologist revealed segments of pituitary tissue, partly
infiltrated by lymphocytes plasma cells and fibrous (Fig. 3a,
b). No organism was identified by Grocott’s methenamine
silver (GMS) and Acid fast bacillus (AFB) stains. Based on
Hematoxylin and Eosin (H&E) staining, the specimen
was diagnosed as lymphocytic hypophysitis. IgG4-related
hypophysitis was not aware at that time since the clinical
manifestation and imaging were compatible with lympho-
cytic hypophysitis. The patient was treated as lymphocytic
hypophysitis. Clinically, his headache resolved, his seizure
remained in remission and he appropriately regained
weight. Following his clinical improvements, prednisolone
was subsequently reduced to 10 mg per day. In February
2014, subsequent pituitary MRI showed the same sellar-
suprasellar mass with no change in size or shape; however,
the lesion at right frontal lobe disappeared (Fig. 1c, d).
The patient also remained seizure free after the initial
steroid administration. In May 2014, prednisolone was
further reduced to 7.5 mg per day.
Three months later, he developed new onset frontal
headache and acute visual loss. Ocular examination dem-
onstrated bitemporal hemianopsia. Pituitary MRI revealed
slightly decrease in size and less bulbous appearance of
the sellar-suprasellar mass but the lesion still abutted to
the optic chiasm with mild compression and mild upward
Fig. 1 Magnetic resonance imaging of the brain. a-b T2W and T1W with Gadolinium contrast images on September 17, 2013. MRI scan showed
hypersignal intensity and gyral contrast enhancement at the right frontal lobe lesion. c-d On February 17, 2014, after steroid initiation, MRI scan
showed complete resolution of the right frontal lobe lesion
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displacement of the optic chiasm. The study also showed
more hyperintense T2W change and mild heterogeneous
enhancement at the optic chiasm, suggesting an increase
in swelling of the optic chiasm (Fig. 2c, d). His serum
IgG4 was 0.792 g/L (0.030-2.010). However, the following
report from external pathology laboratory indicated that
the pituitary tissue carried a large area of lymphoplasma-
cytic infiltration with quite prominent mature plasma cell
population and storiform collagenous fibrosis. IgG4 re-
lated hypophysitis was suspicious and immunohistochem-
ical studies were performed. The block of pituitary tissue
in September 2013 was recut and stained with CD138,
IgG, and IgG4 immunohistochemical stain by immuno-
peroxidase technique. CD138 revealed 100–200 plasma
cells per high power field. IgG and IgG4 showed up to
80 IgG4 positive plasma cells (Fig. 3c) with IgG4/IgG
ratio up to 42 %. Computerized tomography scan of
neck, chest, whole abdomen, and pelvis were also per-
formed to search for other internal organ involvement
of IgG4-related disease. These studies did not detect any
abnormality. Prednisolone was promptly increased to
60 mg per day. Two weeks after prednisolone increment,
headache disappeared; the visual field became normal in
his left eye while temporal hemianopia persisted in his
right eye. Prednisolone was gradually decreased to 30 mg
per day. Four weeks later, his right visual field became
normal. Prednisolone was further declined to 20 mg per
day for 4 weeks then maintained at the dose of 10 mg per
day. Pituitary MRI at 4 months after established diagnosis
showed markedly decrease in size of sellar mass and de-
crease in swelling of the optic chiasm (Fig. 2e, f ) without
abnormal brain parenchymal lesion. Two months later,
prednisolone was decrease to 7.5 mg per day. Phenytoin
was discontinued after one year of seizure-free period.
Statin and aspirin were also ceased following the diagnosis
of cerebral involvement of IgG4. The seizure, headache,
and visual impairment have continued to be asymp-
tomatic up to one year after established diagnosis. The
Fig. 2 Magnetic resonance imaging of the pituitary. a-b T2W and T1W with Gadolinium contrast images on September 17, 2013. MRI scan showed
sellar mass abutted to optic chiasm. c-d On September 2, 2014, the patient developed new temporal hemianopia. There was increase contrast
enhancement in T1W and increase intensity in T2W at optic chiasm but slightly decreased in size of sellar mass. e-f On January 13, 2015, after
treatment of high dose steroid, the sellar mass and intensity in T2W at optic chiasm were markedly decreased
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hormonal assessment at 2 years after presentation remained
adrenal insufficiency and hypothyroid. Although there was
an increase in sex hormone and IGF-1 levels (Table 1).
Discussion
We report a case of biopsy-proven IgG4-related hypophy-
sitis which clinically mimicked a recurrent lymphocytic
hypophysitis. Our patient presented with focal seizure and
multiple anterior pituitary hormone deficiency. He had
typical imaging changes for hypophysitis with vividly
enhanced sellar-suprasellar mass and stalk enlargement.
The pituitary histopathology showed infiltration of lym-
phocytes, plasma cells and fibrosis, reflecting chronic
inflammatory lesions. From the combination of clinical
manifestation, imaging, and initial histopathology; the first
impression was lymphocytic hypophysitis. The diagnosis
of IgG-4 related hypophysitis was obtained one year later
after pathological review.
IgG4-related hypophysitis is a new entity of primary
hypophysitis. Like other organ involvements in IgG4-
related disease, histopathology is the cornerstone for
diagnosis. It is characterized by the infiltration of IgG4-
Fig. 3 Pituitary histopathology. a Pituitary tissue was infiltrated by lymphocytes and plasma cells. b Fibrous tissue and plasma cells were partly
found. c Immunohistochemical study, there was up to 80 per high power field of IgG4 positive plasma cells
Table 1 Endocrine assessment at presentation before glucocorticoid initiation and two years after presentation
Parameters At presentationa (Normal value) Two years after presentationb (Normal value)c
8 AM cortisol (μg/dL) 0.31 (3.7–19.4) <0.40 (3.7–19.4)
Adrenocorticotropic hormone; ACTH (pg/mL) <10 (0–71) <1.6 (4.7–48.8)
Free triiodothyronine; FT3 (pg/mL) 1.71 (1.80–4.60) Not done
Free thyroxine; FT4 (ng/dL) 0.25 (0.93–1.71) 0.59 (0.70–1.48)
Thyroid stimulating hormone; TSH (mIU/L) 1.990 (0.270–4.210) 1.962 (0.350–4.940)
Testosterone (ng/dL) 3 (280–300) 463 (280–300)
Follicle-stimulating hormone; FSH (mIU/mL) 2.10 (1.50–14.20) <0.05 (0.95–11.95)
Lutheinizing hormone; LH (mIU/mL) 0.11 (1.70–8.60) 0 (0.57–12.07)
Insulin-like growth factor 1; IGF-1 (ng/mL) 77.50 (101.00–267.00) 96.41 (101.00–267.00)
Prolactin (ng/mL) 9.67 (4.04–15.20) 1.37 (3.46–19.40)
Peak serum cortisol after administration of 250 μg
corticotropin (μg/dL)
4.19 Not done
Serum osmolarity (mOSm/kgH2O) 274 (275–295) Not done
Urine osmolarity (mOSm/kgH2O) 625 (50–1400) Not done
aBefore steroid initiation
bAll hormonal replacement and steroid were discontinued before laboratory assessment as follows: Prednisolone (3 days), Levothyroxine (1 week), and
Testosterone enanthate (3 weeks)
cNormal values were changed due to the Hospital laboratory was reorganized
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containing plasma cells, lymphocytes, and storiform fibro-
sis. In 2011, Leporati et al. proposed three criteria for
diagnosis of IgG4-related hypophysitis [2]. Fulfillment of
any of these three criteria is sufficient for the diagnosis to
be made. The first criterion requires a histopathological
biopsied of pituitary that shows mononuclear cells infiltra-
tion with more than 10 IgG4-positive cells per high power
field. The second criterion requires a pituitary MRI that
reveals typical lesions for hypophysitis and a tissue biopsy
from another organ showing IgG4 lesion. The third criter-
ion is composed of three components including typical
hypophysitis lesions from MRI imaging, an increase in
serum IgG4 levels and prompt clinical response to ste-
roids. Clearly the uses of second criterion are rather
limited in patients with isolated hypophysitis IgG4-related
disease such as in this patient.
To diagnose IgG4-related hypophysitis without evidence
of other organ involvement is challenging. Routine H&E
staining in histopathology is not sufficient to differentiate
IgG4-related hypophysitis from other causes of chronic
hypophysitis. The immunohistochemistry stain for IgG4
in the pituitary tissue biopsy is a useful tool to help estab-
lish a diagnosis. However, certain limitations exist in this
technique. Firstly sampling error from inadequate speci-
mens can result in a negative report. Secondly, clusters of
IgG4-positive cells can also be found in other causes of
hypophysitis [4, 5]. Lastly, there is also a report in the
paucity of IgG4-positive plasma cells from pituitary tissue,
despite having IgG4-positive plasma cell in other organs
[6]. Multiple other pitfalls also exist in using clinical
criteria to differentiate IgG4-related hypophysitis from
lymphocytic hypophysitis. For example, serum IgG4
level may be normalized after initial steroid adminis-
tration [3, 4]. This is particularly common in patients
with hypocortisolism-associated hypophysitis. The sellar
mass and/or thickened pituitary stalk in pituitary MRI
are also commonly found in other causes of hypophy-
sitis. The dramatic response to steroid therapy, includ-
ing clinical improvement, regression of sellar mass and
resolution of associated inflammation, can also be wit-
nessed in lymphocytic hypophysitis. Thus, a high index
of suspicious is required to establish a diagnosis of
IgG4-related hypophysitis.
Patient backgrounds and clinical courses can serve as
useful tools in differentiating isolated-IgG4 related hypo-
physitis from Lymphocytic hypophysitis. Lymphocytic
hypophysitis is typically found in female whereas IgG4-
related hypophysitis is more common in elderly male with
Asian ethnicity [3]. The recurrence or worsening of clin-
ical symptoms while receiving steroid therapy is unusual
in patients with lymphocytic hypophysitis. Their clinical
symptoms are rather stable with most experiencing grad-
ual improvement after physiologic or supraphysiologic
dosage of steroid therapy [7, 8]. In contrast, patients with
IgG4-related hypophysitis can experience relapse of symp-
toms when receiving steroid therapy. To the best of our
knowledge, 38 cases (include this case) of IgG-4 related
hypophysitis, have been reported in English literatures and
were all compatible with Leporati’s criteria [2, 6, 9–34]. In
these reports, 24 cases were male, 28 cases were Asian
and the median age of onset was 67 years. Up to six cases
revealed enlarging masses on imaging or developed new
symptom relating to the sellar mass during steroid therapy
[2, 6, 11, 18, 27]. These symptoms included visual disturb-
ance, headache, diabetes insipidus or progression of hypo-
pituitarism. Steroid dosage at the point of relapse varied
from 30 mg of prednisolone per day to hydrocortisone
replacement therapy. All patients eventually required
up-titration of steroid or additional immunosuppressive
therapy to control their relapsing clinical symptoms. Five
out of six cases were also initially diagnosed with lympho-
cytic hypophysitis where three of these cases also had pi-
tuitary biopsy and histopathology study prior to their
diagnosis (Table 2).
This patient presented with frontal lobe seizure semi-
ology that did not recur after steroid initiation. Frontal
lobe lesion in MRI also completely regressed after low
dose steroid administration. This clinical picture is un-
usual for cerebral infarctions, therefore statin and aspirin
are futile for secondary prevention of stroke. Although, no
parenchymal tissue was obtained, IgG4-related disease
involvement was highly suspected. Biopsy-proven central
nervous system involvement in IgG4-related disease was
also reported [35, 36]. Unlike our patient, the reported
patients presented with tremor, dementia and weakness.
Various reports also described cases of IgG4-related hypo-
physitis with parasellar inflammation, sinusitis, and pachy-
meningitis [2, 15, 27, 29]. Thus, we speculated that the
newly developed visual field defect in this patient, despite
decreasing in size of sellar mass, could be attributed to as-
sociate pachymeningitis around sellar and optic chias-
matic area. Hence, the escalation of systemic steroid was
sufficient to control the patient symptoms and surgical
intervention was unnecessary.
Despite an absence of posterior bright spot in MRI, the
patient had no sign and symptom of diabetes insipidus.
The absence of posterior bright spot in MRI was reported
in about 0 to 25 % of normal subjects [37, 38]. However,
our patient had anterior pituitary dysfunction with mass
and enlarged stalk; hence we suspected that some degree
neurohypophyseal inflammation existed without causing
gross disturbance in vasopressin secretion. This inflamma-
tion only resulted in a partial depletion of vasopressin
which was asymptomatic and normal range of urine
osmolarity was preserved. Other case reports of IgG4-
related hypophysitis also showed an absence of posterior
bright spot in MRI imaging in patients without clinical
diabetes insipidus [11, 23]. Thus, closed monitoring for
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Table 2 Clinical characteristic of relapsing of Immunoglobulin G4 (IgG4)-related hypophysitis during steroid therapy
Author, year Sex, age,
race
Manifestations before steroid treatment Steroid type and dosage Symptoms and signs after steroid
treatment





Autoimmune pancreatitis, uveitis, organizing
pneumonia, panhypopituitarism with mass
(Lymphocytic hypophysitis)b
Pred 50 mg/day for 1 week
then taper to 10 mg/day
within 7 months
Recurrent pituitary mass and
organizing pneumonia






Diabetes insipidus and gradual loss of anterior
pituitary function with mass (Lymphocitic
hypophysitis)b, retroperitoneal fibrosis
Hydrocortisone
replacement for 4 years
Headache, pituitary swelling Pred 30 mg/day for 2 weeks then 10 mg/day,
decrease pituitary swelling
Leporati, 2011 [2] M 75 y,
Caucasian
Panhypopituitarism with mass, sphenoid mass Pred 40 mg/day taper to
10 mg/day over 4 weeks
Recurrent headache Pred 15 mg/day, then taper/reescalation and
suspend until 1.3 years, improved headache
but hypopituitarism
Caputo, 2014 [27] M 40 y,
Vietnamese
Lacrimal gland mass, diabetes insipidus,
panhypopituitarism with mass (Lymphocytic
hypophysitis)a, enlarged infraorbital nerve
Pred 30 mg/day for
3 months
Enlarging pituitary mass with
new optic nerve compression
Azathioprine 75 mg twice daily whilst weaning
Pred for 10 months, recovery from adrenal
insufficiency and growth hormone deficiency,
ongoing bilaterally enlarged infraorbital nerves
but normal pituitary size
Ohkubo, 2013 [6] M 70 y,
Japanese
Hashimoto’s thyroiditis, pancreatic and
retroperitoneal mass, salivary gland enlargement,
pituitary mass, bitemporal hemianopsia
(Lymphocytic hypophysitis)a
Pred 40 mg/day for
2 weeks then taper to
5 mg/day
Reduction in pituitary lesion,
improved vision but new DI
and panhypopituitarism
Pred 30 mg/day then taper to 5 mg/day for
2 months, no further pituitary mass reduction
and did not restore the pituitary function
Hydrocortisone 100 mg on







Frontal lobe seizure, multiple pituitary hormone
deficiency with pituitary mass (Lymphocytic
hypophysitis)a
Pred 15 mg/day for 6 weeks,
10 mg/day for 3 months, and




Pred 60 mg/day for 2 weeks, gradually
decrease to 30 mg/day for 4 weeks,
20 mg/day for 4 weeks, and 10 mg/day
for maintenance, complete recovery of
vision, contracted pituitary mass, decreased
optic chiasmatic swelling, but did not
restore pituitary function
Pred Prednisolone, mg milligrams
aInitial diagnosis based on initial histopathology















diabetes insipidus is warranted. One year after steroid
escalation, there was an improvement in gonadal function
and pituitary mass was controlled. Nevertheless, most of
anterior pituitary hormones still depressed. Long term
follow up is recommended for understanding the natural
course of IgG4-related hypophysitis.
Conclusion
This is the first case report in patient with IgG4-related
hypophysitis who initially presented with focal seizures
and relapsing lymphocytic hypophysitis. Due to its rarity
and the overlapping clinical picture, it is often difficult
to differentiate IgG4-related hypophysitis from lympho-
cytic hypophysitis with initial clinical manifestations, im-
aging studies, and routine histopathology. This case report
highlights the distinctive clinical course between the two
diseases. A close clinical follow-up is, therefore, essential
in patients with lymphocytic hypophysitis. A diagnosis
of IgG4-related hypophysitis should be considered in
patients with worsening clinical course during the steroids
decrement or patients with concomitant pachymeningitis.
These patients should undergo further evaluation in-
cluding clinical assessment for other organ involvement,
measuring serum IgG4 level and additional tissue immu-
nostaining. Timely treatment with high dose steroid is
advised to prevent permanent disability and unnecessary
invasive surgical interventions.
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